Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
2.890
-0.550 (-15.99%)
Mar 31, 2025, 1:29 PM EDT - Market open
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $136.48 million as of March 31, 2025. Its market cap has decreased by -88.54% in one year.
Market Cap
136.48M
Enterprise Value
15.24M
1-Year Change
-88.54%
Ranking
Category
Stock Price
$2.89
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $136.48M, a decrease of -74.65%. That is a compound annual growth rate of -26.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 162.45M | -49.99% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | 610.91M | 13.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |